These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25434944)

  • 1. To fractionate or not to fractionate? That is the question for the radiosurgery of hypoxic tumors.
    Toma-Dasu I; Sandström H; Barsoum P; Dasu A
    J Neurosurg; 2014 Dec; 121 Suppl():110-5. PubMed ID: 25434944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of radiosurgery fractionation and tumor radiobiology on the local control of brain metastases.
    Oermann EK; Kress MA; Todd JV; Collins BT; Hoffman R; Chaudhry H; Collins SP; Morris D; Ewend MG
    J Neurosurg; 2013 Nov; 119(5):1131-8. PubMed ID: 24010977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved effectiveness of stereotactic radiosurgery in large brain metastases by individualized isotoxic dose prescription: an in silico study.
    Zindler JD; Schiffelers J; Lambin P; Hoffmann AL
    Strahlenther Onkol; 2018 Jun; 194(6):560-569. PubMed ID: 29349605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Control Probability of Radiosurgery and Fractionated Stereotactic Radiosurgery for Brain Metastases.
    Redmond KJ; Gui C; Benedict S; Milano MT; Grimm J; Vargo JA; Soltys SG; Yorke E; Jackson A; El Naqa I; Marks LB; Xue J; Heron DE; Kleinberg LR
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):53-67. PubMed ID: 33390244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A modified hypoxia-based TCP model to investigate the clinical outcome of stereotactic hypofractionated regimes for early stage non-small-cell lung cancer (NSCLC).
    Strigari L; Benassi M; Sarnelli A; Polico R; D'Andrea M
    Med Phys; 2012 Jul; 39(7):4502-14. PubMed ID: 22830782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment fractionation for stereotactic radiotherapy of lung tumours: a modelling study of the influence of chronic and acute hypoxia on tumour control probability.
    Lindblom E; Antonovic L; Dasu A; Lax I; Wersäll P; Toma-Dasu I
    Radiat Oncol; 2014 Jun; 9():149. PubMed ID: 24974778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of radiation dose spillage from the Gamma Knife Perfexion with that from volumetric modulated arc radiosurgery during treatment of multiple brain metastases in a single fraction.
    McDonald D; Schuler J; Takacs I; Peng J; Jenrette J; Vanek K
    J Neurosurg; 2014 Dec; 121 Suppl():51-9. PubMed ID: 25434937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal fractionation in radiotherapy for non-small cell lung cancer--a modelling approach.
    Lindblom E; Dasu A; Toma-Dasu I
    Acta Oncol; 2015; 54(9):1592-8. PubMed ID: 26217986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stochastic Predictions of Cell Kill During Stereotactic Ablative Radiation Therapy: Do Hypoxia and Reoxygenation Really Matter?
    Harriss-Phillips WM; Bezak E; Potter A
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1290-7. PubMed ID: 27212197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computed 88% TCP dose for SBRT of NSCLC from tumour hypoxia modelling.
    Ruggieri R; Stavreva N; Naccarato S; Stavrev P
    Phys Med Biol; 2013 Jul; 58(13):4611-20. PubMed ID: 23771131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic radiotherapy for large solitary brain metastases.
    Feuvret L; Vinchon S; Martin V; Lamproglou I; Halley A; Calugaru V; Chea M; Valéry CA; Simon JM; Mazeron JJ
    Cancer Radiother; 2014 Mar; 18(2):97-106. PubMed ID: 24439342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fractionated stereotactic radiotherapy using CyberKnife for the treatment of large brain metastases: a dose escalation study.
    Murai T; Ogino H; Manabe Y; Iwabuchi M; Okumura T; Matsushita Y; Tsuji Y; Suzuki H; Shibamoto Y
    Clin Oncol (R Coll Radiol); 2014 Mar; 26(3):151-8. PubMed ID: 24332223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of multiple brain metastases with a divide-and-conquer spatial fractionation radiosurgery approach.
    Kelly DA
    Med Hypotheses; 2014 Oct; 83(4):425-8. PubMed ID: 25175716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
    Xue J; Kubicek GJ; Grimm J; LaCouture T; Chen Y; Goldman HW; Yorke E
    J Neurosurg; 2014 Dec; 121 Suppl():60-8. PubMed ID: 25434938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cyberknife radiosurgery/radiotherapy for brain metastases of multiple or large-size tumors.
    Nishizaki T; Saito K; Jimi Y; Harada N; Kajiwara K; Nomura S; Ishihara H; Yoshikawa K; Yoneda H; Suzuki M; Gibbs IC
    Minim Invasive Neurosurg; 2006 Aug; 49(4):203-9. PubMed ID: 17041830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of hypofractionation on simultaneous dose-boosting to hypoxic tumor subvolumes.
    Ruggieri R; Nahum AE
    Med Phys; 2006 Nov; 33(11):4044-55. PubMed ID: 17153384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reoxygenation of hypoxic cells by tumor shrinkage during irradiation. A computer simulation.
    Kocher M; Treuer H
    Strahlenther Onkol; 1995 Apr; 171(4):219-30. PubMed ID: 7740410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes of biological effective dose-based fractionated stereotactic radiation therapy for metastatic brain tumors from non-small cell lung cancer.
    Matsuyama T; Kogo K; Oya N
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):984-90. PubMed ID: 23092725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractionated stereotactic radiosurgery for large brain metastases.
    Wegner RE; Leeman JE; Kabolizadeh P; Rwigema JC; Mintz AH; Burton SA; Heron DE
    Am J Clin Oncol; 2015 Apr; 38(2):135-9. PubMed ID: 23563213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.